- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lung RFA's midterm results beat expectations
More than 90% of patients undergoing radiofrequency ablation for primary and secondary lung cancer could outlive their treatment for two years or longer, provided they don't succumb to other causes. Researchers from Italy reported these findings at the Society of Interventional Radiology meeting in April.
More than 90% of patients undergoing radiofrequency ablation for primary and secondary lung cancer could outlive their treatment for two years or longer, provided they don't succumb to other causes. Researchers from Italy reported these findings at the Society of Interventional Radiology meeting in April.
Dr. Riccardo Lencioni and colleagues at the University of Pisa treated 186 nonoperable tumors in 106 patients enrolled in the multicenter Radiofrequency Ablation of Pulmonary Tumors Response Evaluation (RAPTURE) trial. The study included 33 patients with non-small cell lung cancer, 53 with colorectal cancer metastases, and 20 with metastases from other types of malignancy.
RFA yielded high local tumor control rates and cancer-specific survival outcomes for patients with NSCLC or CRC metastases. CT follow-up three months after the procedure confirmed ablation's effectiveness rate at 93%. Cancer-specific survival rates for NSCLC and CRC metastases were 91% and 88% at one year and 91% and 72% at two years, respectively.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
